1-2 of 2
Darlene Lagrone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.

M. Domenica Cappellini, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Marcello Capra, Duran Canatan, Guillermo Drelichman, Yurdanur Kilinc, Carmelo Magnano, John B. Porter, Antonio Piga, Louis Griffel, Darlene Lagrone, Joan Clark, Antonis Kattamis
Journal: Blood
Blood (2009) 114 (22): 4063.
https://doi.org/10.1182/blood.V114.22.4063.4063
Published: 2009
Journal Articles

Long-Term Efficacy and Safety of Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, in Patients with Sickle Cell Disease (SCD).

Elliott Vichinsky, Thomas D. Coates, Alexis A. Thompson, Brigitta U. Mueller, Darlene Lagrone, Matthew M. Heeney
Journal: Blood
Blood (2007) 110 (11): 3395.
https://doi.org/10.1182/blood.V110.11.3395.3395
Published: 2007